REVIA 50mg film-coated tablets CHIESI
naltrexone Indicated for: opioid dependence; alcohol dependence
N07BB04 Nervous system | Drugs used in addictive disorders | Drugs used in alcohol dependence
letter R · page 26
naltrexone Indicated for: opioid dependence; alcohol dependence
N07BB04 Nervous system | Drugs used in addictive disorders | Drugs used in alcohol dependence
acetylcysteine Indicated for: viscous bronchial secretions; paracetamol overdose
R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
paracetamol + guaifenesin + phenylephrine Indicated for: cold and flu symptoms
N02BE51 Nervous system | Other analgesics and antipyretics | Anilides
combinations Indicated for: various therapeutic indications
N02BE51 Nervous system | Other analgesics and antipyretics | Anilides
paracetamol + pseudoephedrine Indicated for: cold and flu symptoms
N02BE51 Nervous system | Other analgesics and antipyretics | Anilides
combinations Indicated for: various therapeutic indications
acetylcysteine Indicated for: viscous bronchial secretions; paracetamol overdose
R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
lenalidomide Indicated for: multiple myeloma
lenalidomide Indicated for: multiple myeloma
lenalidomide Indicated for: multiple myeloma
lenalidomide Indicated for: multiple myeloma
exemestane Indicated for: breast cancer
eltrombopag Indicated for: thrombocytopenia
eltrombopag Indicated for: thrombocytopenia
paroxetine Indicated for: depression; anxiety disorders
N06AB05 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
paricalcitol Indicated for: hyperparathyroidism
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors